Biopharmaceutical company.
Legislative proposals to smooth out of pocket costs for patients in Medicare Part D.

FY 2021 Notice of Benefits and Payment Parameters proposed rule. Education about the 340(b) drug discount program.
MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 2 - HOUSE OF REPRESENTATIVES
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX